Understanding Familial Hyperaldosteronism Type I (FH-I)

Familial Hyperaldosteronism Type I (FH-I), also known as Glucocorticoid-Remediable Aldosteronism (GRA), is a rare genetic condition that causes the body to produce too much of the hormone aldosterone ^[1]. While most high blood pressure in adults is “essential” (no single known cause), FH-I is a “secondary” cause, meaning the high blood pressure is a direct result of this specific genetic change ^[2].

FH-I is exceptionally rare. Familial forms as a group account for an estimated 1% to 5% of all cases of primary aldosteronism (a condition where the adrenal glands produce too much aldosterone), and FH-I makes up only a small fraction of those ^[3][4]. Because it is so uncommon, it is often only discovered when high blood pressure appears very early in life—frequently before age 20—or when multiple family members are affected ^[5][6].

The Genetic “Switch”: The Chimeric Gene

To understand FH-I, it helps to look at two genes that live next door to each other on chromosome 8: CYP11B1 and CYP11B2 ^[7].

• CYP11B1 is responsible for making cortisol, a hormone regulated by daily rhythms and stress signals from the brain via ACTH (adrenocorticotropic hormone) ^[1].
• CYP11B2 is responsible for making aldosterone, which is normally regulated by the body’s renin-angiotensin system to help balance salt and blood pressure ^[8].

In patients with FH-I, a biological error called unequal crossover occurs. The two genes get tangled and swap parts, creating a “fusion” or chimeric gene ^[1][7]. This new hybrid gene has the “engine” of the aldosterone gene but the “on-switch” of the cortisol gene ^[1].

As a result, your body starts producing aldosterone in response to normal daily pulses of ACTH instead of the normal blood pressure sensors ^[8][9]. This inappropriate signal causes the adrenal glands to flood the body with excess aldosterone ^[1].

How FH-I is Inherited

FH-I follows an autosomal dominant inheritance pattern ^[10]. This means:

• A person only needs one copy of the chimeric gene to have the condition ^[11].
• An affected parent has a 50% chance (1 in 2) of passing the gene variant to each child ^[10].
• While the genetic variant itself does not skip generations, the severity and age of onset of high blood pressure can vary greatly from person to person ^[5]. Because some relatives may have mild or unrecognized hypertension, the disease can sometimes appear to skip a generation.

Once a familial fusion is confirmed, experts recommend cascade testing and genetic counseling for all first-degree relatives ^[1]. This includes relatives who currently have normal blood pressure, as identifying the gene early allows for baseline monitoring before severe hypertension develops.

Why Early Detection Matters

Because the blood pressure in FH-I is driven by a constant hormone signal rather than standard age-related factors, it can be severe and begin in childhood ^[6]. If left untreated, the high pressure can cause damage to the heart and blood vessels earlier than expected ^[6].

• Target-Organ Injury: Some patients may develop premature left ventricular hypertrophy (thickening of the heart muscle) or hypertensive retinopathy (damage to the eyes) ^[6].
• Stroke Risk: Case reports and small family studies have documented an association between FH-I and an increased risk of strokes or intracranial aneurysms (weak spots in brain arteries), sometimes before age 40 ^[12][11]. However, these are largely reported associations from specific cohorts, and they do not mean an aneurysm is an absolute certainty for every patient. Risk reduction depends heavily on strict blood-pressure control.

Signs and Diagnosis

The most common “red flag” for FH-I is severe hypertension in a child or young adult ^[2]. Other clues include:

1. Suppressed Renin: Blood tests often show very low levels of renin (the hormone that should be triggering aldosterone) because the body is trying to shut down the system ^[13][1].
2. Family History: A history of early stroke or family members with high blood pressure ^[12].
3. Potassium Levels: While some people have low potassium (hypokalemia), many patients with FH-I have completely normal potassium levels, so a normal test does not rule the condition out ^[14][1].

Confirmation requires specialized genetic testing to find the specific CYP11B1/CYP11B2 fusion gene ^[12]. Once identified, doctors use low doses of glucocorticoids (steroids) to suppress the ACTH signal, which in turn reduces the abnormal aldosterone production ^[1].